Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Simple Summary Invasive lobular breast cancer (ILC) is a special type of breast cancer (BC)
that was first described in 1941. The diagnosis of ILC is made by microscopy of tumor …

This dataset was developed without external funding to the writing group. The College
requires the authors of datasets to provide a list of potential conflicts of interest; these are …

Background/Aim: Despite the large amount of clinical data available of Coronavirus-19
(COVID-19), not many studies have been conducted about the psychological toll on Health …

Lobular carcinoma is a special type of breast cancer that shows distinct clinical presentation,
morphologic and molecular features, and clinical behavior, and its incidence is rising in …

OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …

The clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ
(PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are poorly defined. In this …

Standardized recommendations for the management of lobular neoplasia in core biopsy
specimens are not established. The aim of our study was to define morphologic features of …

Pleomorphic lobular carcinoma in situ (PLCIS) is a more recently characterized entity that
mimics high-grade ductal carcinoma in situ (DCIS). PLCIS is sometimes treated similar to …

This dataset was developed without external funding to the writing group. The College
requires the authors of datasets to provide a list of potential conflicts of interest; these are …